for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Livongo Health Inc

LVGO.OQ

Latest Trade

120.88USD

Change

0.00(-0.00%)

Volume

2,760,839

Today's Range

119.26

 - 

135.87

52 Week Range

15.12

 - 

149.84

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
120.88
Open
134.35
Volume
2,760,839
3M AVG Volume
104.72
Today's High
135.87
Today's Low
119.26
52 Week High
149.84
52 Week Low
15.12
Shares Out (MIL)
97.82
Market Cap (MIL)
11,824.12
Forward P/E
-2,403.18
Dividend (Yield %)
--

Next Event

Q3 2020 Livongo Health Inc Earnings Release

Latest Developments

More

Teladoc Health Says Livongo Obligated To Pay To Teladoc Termination Fee Of $562.8 Million If Merger Agreement Terminated

Teladoc Health, Livongo Merge, Total Deal Value Of $18.5 Billion

Livongo Health Q2 GAAP Loss Per Share $0.02

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Livongo Health Inc

Livongo Health, Inc. is a consumer digital health company. The Company offers Enter Livongo platform, which leverages data science and technology, creates a personalized experience for people with chronic conditions. The Company focuses on developing an approach for diabetes management that combines technology with coaching. The Company’s Livongo platform offers a range of solutions, such as Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management and Livongo for Behavioral Health by myStrength. The Company uses a digital approach to delivering evidence-based interventions including cognitive behavioral therapy, acceptance and commitment therapy, positive psychology, mindfulness, and motivational interviewing to help resolve clinical conditions, build resiliency, manage stress, improve mood, sleep better, or simply find daily inspiration.

Industry

Healthcare Facilities

Contact Info

150 W Evelyn Ave

MOUNTAIN VIEW, CA

94041-1555

United States

+1.312.3575450

https://www2.livongo.com/

Executive Leadership

Glen E. Tullman

Executive Chairman of the Board

Jennifer J Schneider

President

Zane M. Burke

Chief Executive Officer, Director

Lee A. Shapiro

Chief Financial Officer

James Pursley

Chief Commercial Officer

Key Stats

1.89 mean rating - 18 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2019

0.2K

2020(E)

0.4K
EPS (USD)

2019

-0.390

2020(E)

0.087
Price To Earnings (TTM)
--
Price To Sales (TTM)
45.83
Price To Book (MRQ)
20.45
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
68.57
LT Debt To Equity (MRQ)
68.57
Return on Investment (TTM)
-5.82
Return on Equity (TTM)
-5.41

Latest News

Latest News

Teladoc bets big on online medicine with $18.5 billion Livongo deal

Teladoc Health Inc <TDOC.N> has agreed to buy chronic care provider Livongo Health Inc <LVGO.O> in a deal valuing the company at $18.5 billion, betting on a boom in online care and consultations spurred by the coronavirus crisis.

Virtual care company Teladoc to buy Livongo in $18.5 bln deal

Teladoc Health said on Wednesday it would buy Livongo Health Inc in a deal valued at $18.5 billion, in a bid to create a leader in virtual care.

BRIEF-Livongo Health Sees Q2 2020 Revenue $86 Mln To $87 Mln

* LIVONGO ANNOUNCES PRELIMINARY SECOND QUARTER 2020 REVENUE; EXCEEDS PREVIOUSLY ANNOUNCED GUIDANCE

BRIEF-Livongo Reports Pricing Of Upsized $475.0 Mln Convertible Senior Notes Offering

* LIVONGO ANNOUNCES PRICING OF UPSIZED $475.0 MILLION CONVERTIBLE SENIOR NOTES OFFERING

BRIEF-Livongo Offers $400 Mln Of Convertible Senior Notes Due 2025

* LIVONGO ANNOUNCES PROPOSED OFFERING OF $400.0 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2025

BRIEF-Livongo Health Q1 Revenue $68.8 Million Versus Refinitiv IBES Estimate Of $65.8 Million

* Q1 REVENUE $68.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF $65.8 MILLION

BRIEF-Livongo Says Preliminary Q1 2020 Revenue Exceeds Previously Announced Guidance

* LIVONGO ANNOUNCES PRELIMINARY FIRST QUARTER 2020 REVENUE; EXCEEDS PREVIOUSLY ANNOUNCED GUIDANCE

BRIEF-Livongo Expands Relationship With CVS Health

* LIVONGO EXPANDS RELATIONSHIP WITH CVS HEALTH, NOW PART OF CHRONIC CONDITION MANAGEMENT PLATFORM WITHIN POINT SOLUTIONS SERVICE

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up